Sep 2026
IRF1-driven chromatin and transcriptional regulation determines the anti-tumor responses to all-trans retinoic acid across cancer types.
It is indicated that IRF1-dependent chromatin and transcriptional regulation contribute to the diverse anti-tumor effects of ATRA and provide a framework for biomarker-guided evaluation of ATRA in cancer therapies.
W. Jin, Peng Jin, Yun Tan et al.
· Biochemical Pharmacology · 1 citation